In episode 29 of Cutaneous Miscellaneous, our host, Nicholas Brownstone, MD, is joined by dermatologist Graham Litchman, DO, and Tobin Dickerson, PhD, chief scientific officer and cofounder of Mindera Health, to explore an innovative technology in psoriasis management. Drs Brownstone and Litchman begin with a board review on HPV and warts, highlighting key HPV types, their associated warts, and helpful mnemonic devices to aid memorization. They then discuss Tobin Dickerson’s development of the Mind.Px dermal patch, a groundbreaking tool designed to optimize treatment decisions for psoriasis patients. Dr Litchman shares his approach to selecting biologics and how the Mind.Px test integrates into clinical workflows, from improving prior authorization to enhancing patient outcomes. The episode concludes with a look at the MATCH1 and STAMP2 studies validating this technology and advice for residents on getting involved with this cutting-edge tool. Tune in for essential board review tips and to learn how the Mind.Px dermal patch is shaping the future of psoriasis treatment! References: Strober B, Bukhalo M, Armstrong A, et al. Interim clinical utility findings of a transcriptomic psoriasis biologic test demonstrate altered physician prescribing behavior and improved patient outcomes. SKIN J Cutan Med. 2022;6(6):458-462. doi:10.25251/skin.6.6.2 Bagel J, Wang Y, Montomery P III, et al. A machine learning-based test for predicting response to psoriasis biologics. SKIN J Cutan Med. 2021;5(6):621-638. doi:10.25251/skin.5.6.5

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related